[ U.S. CDMRP – Peer-Reviewed Cancer Research Program Impact Award | Research Funding ]
Event details
| Date | 14.05.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Peer-Reviewed Cancer Research Program (PRCRP) Awards. The PRCRP Idea Award supports hypothesis-driven, high-impact research. The Impact Award mechanism encourages applications with mature research projects that specifically focus on critical scientific or clinical cancer issues, which, if successfully addressed, have the potential to make a major impact on at least one of the FY20 PRCRP Topic Areas (see end of this announcement). Important factors under consideration will be continuity of research, clinical applicability, and leveraging of clinical samples and trials.
The critical components of this award mechanism are:
Funding: max. $1’000’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. PI applicants must be independent investigators at or above the level of Assistant Professor (or equivalent).
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 14-May-2020, 5:00 p.m. EST
Full Application Deadline: 27-Aug-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PRCRP-IPA
Further information
FY20 Topic Areas
The critical components of this award mechanism are:
- Impact: The Impact Award is intended to support research that demonstrates the potential to have a major impact in the near term on an area of paramount importance in cancer.
- Preliminary Data: The Impact Award is intended to support transformative investigations that leapfrog the cancer research field forward by utilizing previous research findings.
- Continuity of Research: The Impact Award is intended to support established projects that have moved beyond the realm of basic research and have the potential to result in a near-term impact in clinical research or the clinic.
- Military Relevance: The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
Funding: max. $1’000’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. PI applicants must be independent investigators at or above the level of Assistant Professor (or equivalent).
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 14-May-2020, 5:00 p.m. EST
Full Application Deadline: 27-Aug-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PRCRP-IPA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-PRCRP-IPA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 Topic Areas
-
- Bladder cancer
- Blood cancers
- Brain cancer
- Colorectal cancer
- Esophageal cancer
- Head and Neck cancer
- Immunotherapy
- Liver cancer
- Mesothelioma
- Metastatic cancers
- Neuroblastoma
- Pediatric brain tumors
- Pediatric, adolescent, and young adult cancers
- Stomach cancer
Practical information
- General public
- Free